En Es
Categories

MERIDIAN BIOSCIENCE

MERIDIAN BIOSCIENCE

Meridian Bioscience manufactures, markets, and distributes diagnostic test kits, purified reagents and biopharmaceutical-enabling technologies for the early diagnosis and treatment of common medical conditions. Its products are ideal for hospitals, reference laboratories, research centers, physician offices and diagnostic ...
Products Covid-19NewsSummary
Close

Covid-19 MERIDIAN BIOSCIENCE

Clinical Laboratory

SARS-CoV-2 rRT-PCR Test
Revogene SARS-CoV-2

Revogene SARS-CoV-2 is a real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on the Revogene instrument for the detection of SARS-CoV-2 nucleic acid from nasopharyngeal, oropharyngeal, anterior nasal, and mid-turbinate nasal swab specimens. The test can return a positive result as soon as 47 minutes and provides impressive clinical performance with a positive predictive agreement (PPA) of 97.7% and a negative predicative agreement (NPA) of 97.7%.
More details

SARS-CoV-2 Antigen Test
GenBody COVID-19 Ag

GenBody COVID-19 Ag is an immunochromatographic assay kit for the qualitative detection of SARS-CoV-2 antigen in a nasopharyngeal swab from humans. The lateral flow immunoassay offers detection of active infection caused by SARS-CoV-2 in 15 minutes and allows for near patient testing without the need of instrumentation or special equipment.
More details

COVID-19 IgG/IgM Test
QuikPac II 2019 COVID-19

The QuikPac II 2019 COVID-19 IgG and IgM Test is a qualitative test for the detection of IgG and IgM antibodies to COVID-19 in human serum, plasma or whole blood. The test provides a differential detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-IgG antibodies and can be used for the presumptive distinction between a primary and secondary Coronavirus infection.
More details

Molecular Diagnostic Instrument
Revogene

Revogene is a flexible molecular platform capable of single analyte and multiplex testing that is packaged in a small footprint, and can help standardize testing throughout the health system. The fully automated molecular platform offers minimal hands-on time with walk-away efficiencies.
More details

Molecular Reagents
Molecular Reagents

Meridian’s portfolio of RT-qPCR master mixes have been designed to simplify the development of SARS-CoV-2 molecular assays and enable new features such as extraction-free amplification. Each master mix contains a hot-start polymerase, dNTPs, buffer and other components optimized for each particular application (e.g. lyophilization). Only primers and probes are required to complete the assay formula. Meridian has developed an Inhibitor-Tolerant RT-qPCR Mix capable of delivering sensitive multiplex detection, even in the presence of difficult inhibitors found in sputum, saliva and stool specimens. This new mix offers a novel alternative to nucleic acids extraction, saving both time and labor which are vitally important in viral screening assays that require rapid detection for infection control.
More details

SARS-CoV-2 High Sensitivity Antibodies
SARS-CoV-2 High Sensitivity Antibodies

Meridian’s monoclonal antibodies are highly sensitive for the detection of SARS-CoV-2 and they do not cross-react with seasonal coronavirus strains. They are ideal for developing reliable and sensitive rapid lateral flow antigen assays for the detection of active COVID-19 infections.
More details

SARS-CoV-2 Recombinant Antigens
SARS-CoV-2 Recombinant Antigens

Meridian’s recombinant antigens are expressed in human mammalian cells and insect cells using proprietary expression and purification technologies. Expression in either human or insect cells provides for post-translational modifications such as glycosylation and phosphorylation which can offer significant performance advantages over E. coli expressed formats.
More details
Close

News of MERIDIAN BIOSCIENCE

Meridian Bioscience Acquired by SD Biosensor and SJL Partners

08 Jul 2022
Meridian Bioscience Acquired by SD Biosensor and SJL Partners
Meridian Bioscience, Inc. (Cincinnati, OH, USA) and SD Biosensor, Inc. (Seoul, South Korea) and SJL Partners LLC (Seoul, South Korea) have entered into a definitive merger agreement whereby a newly formed affiliate vehicle of the consortium will acquire Meridian in an all-cash transaction valued at approximately USD 1.53 billion.
Read More

Meridian Acquires Euprotein to Further Expand Recombinant Protein Capabilities

03 May 2022
Meridian Acquires Euprotein to Further Expand Recombinant Protein Capabilities
Meridian Bioscience, Inc. (Cincinnati, OH, USA) has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc. (North Brunswick Township, NJ, USA).
Read More
Close

About MERIDIAN BIOSCIENCE

Meridian Bioscience manufactures, markets, and distributes diagnostic test kits, purified reagents and biopharmaceutical-enabling technologies for the early diagnosis and treatment of common medical conditions. Its products are ideal for hospitals, reference laboratories, research centers, physician offices and diagnostics manufacturers.

Recently updated

Streptococcus B Test
Alethia Group B Streptococcus Assay

The Alethia Group B Streptococcus assay is a qualitative in vitro diagnostic for the detection of Streptococcus agalactiae in enriched cultures obtained from vaginal/rectal swab specimens from antepartum women. The test’s molecular precision ensures accurate results and timely administration of appropriate antibiotic therapy for GBS-positive patients.
More details

Streptococcus A Test
Revogene Strep A Assay

The Revogene Strep A assay is for the direct detection of Streptococcus pyogenes (Group A β-hemolytic Streptococcus; GAS) from throat swab specimens obtained from patients with signs and symptoms of pharyngitis. This test can provide final results in as early as 42 minutes for positive specimens.
More details

C. difficile Test
Alethia C.difficile Assay

The Alethia C.difficile assay is a quick, accurate and reliable molecular assay for C. difficile detection. By providing accurate and reliable results, the assay allows for appropriate management and treatment of their patients.
More details

Clinical Laboratory

Streptococcus B Test
Alethia Group B Streptococcus Assay

The Alethia Group B Streptococcus assay is a qualitative in vitro diagnostic for the detection of Streptococcus agalactiae in enriched cultures obtained from vaginal/rectal swab specimens from antepartum women. The test’s molecular precision ensures accurate results and timely administration of appropriate antibiotic therapy for GBS-positive patients.
More details

Streptococcus A Test
Revogene Strep A Assay

The Revogene Strep A assay is for the direct detection of Streptococcus pyogenes (Group A β-hemolytic Streptococcus; GAS) from throat swab specimens obtained from patients with signs and symptoms of pharyngitis. This test can provide final results in as early as 42 minutes for positive specimens.
More details

C. difficile Test
Alethia C.difficile Assay

The Alethia C.difficile assay is a quick, accurate and reliable molecular assay for C. difficile detection. By providing accurate and reliable results, the assay allows for appropriate management and treatment of their patients.
More details

Group B Streptococcus Test
Revogene GBS LB Assay

The Revogene GBS LB assay is a qualitative in vitro diagnostic test to detect Group B Streptococcus (GBS) from vaginal/rectal swab samples, after Lim Broth enrichment, from antepartum pregnant women. The assay provides physicians with accurate and reliable results within 70 minutes, allowing for appropriate treatment decisions of the mother at the time of delivery, ensuring the best outcome for the baby.
More details

POC Blood Lead Poisoning Test
LeadCare II

LeadCare II is the only CLIA waived point-of-care test for blood lead poisoning and can screen in a single visit with a simple finger-stick in just three minutes. The system includes the LeadCare II Blood Lead Analyzer and the LeadCare II Test Kit and is designed for the quantitative measurement of lead in fresh whole blood.
More details

Pneumocystis Test
MERIFLUOR

MERIFLUOR Pneumocystis is an in vitro procedure for the detection of Pneumocystis carinii cysts and trophozoites in direct smears of respiratory tract specimens. It provides a simple, highly specific, direct immunofluorescent procedure for the identification of P. carinii cysts and trophozoites in respiratory tract specimens.
More details

Legionella Rapid Antigen Test
TRU Legionella

TRU Legionella is a Rapid Immunoassay for the detection of Legionella pneumophila serogroup 1 antigens in human urine specimens. It improves lab efficiency with a simple, 3-step procedure and enables physicians to make informed decisions about the management and treatment of their patients.
More details

Automated CLIA Analyzer
LIAISON XL

The LIAISON XL is a fully automated chemiluminescence (CLIA) analyzer that performs complete sample processing using “Flash” CLIA technology with paramagnetic microparticle solid phase. It performs complete sample processing (sample pre-dilutions, sample and reagent dispensing, incubations, wash processes, etc.) as well as measurement and evaluation.
More details

Urea Breath Test System
BreathID Hp

The BreathID Hp urea breath test system for H. pylori detection intuitively combines market-leading diagnostic accuracy with real-time results and convenient follow-up testing in a clinic or point-of-care setting. It offers market-leading performance and compact efficiencies with its real-time results enabling providers to test and treat at the point of care.
More details

SARS-CoV-2 rRT-PCR Test
Revogene SARS-CoV-2

Revogene SARS-CoV-2 is a real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on the Revogene instrument for the detection of SARS-CoV-2 nucleic acid from nasopharyngeal, oropharyngeal, anterior nasal, and mid-turbinate nasal swab specimens. The test can return a positive result as soon as 47 minutes and provides impressive clinical performance with a positive predictive agreement (PPA) of 97.7% and a negative predicative agreement (NPA) of 97.7%.
More details

Campylobacter Enzyme Immunoassay
Premier CAMPY

The Premier CAMPY is an enzyme immunoassay that detects Campylobacter antigens and is intended for testing of stool samples from patients with signs and symptoms of gastroenteritis. The highly sensitive assay provides detection without lengthy and variable culture procedures and has a faster turnaround time of two hours.
More details

Urea Breath Test System
BreathID Smart

The state-of-the-art BreathID Smart urea breath test system for H. pylori detection intuitively combines market-leading diagnostic accuracy with efficient automation, all in a compact footprint for maximizing mid-range testing throughput. The BreathID platform can be used in conjunction with other Meridian H. pylori platforms for a total testing solution across the healthcare system.
More details

Blood Lead Test Analyzer
LeadCare

LeadCare is a blood lead test platform that provides a stand-alone system and features the only CLIA waived system to help core labs, hospital labs, reference labs, or physician’s office labs run more efficiently. It provides accurate, three-minute quantitative blood lead results, allowing physicians to educate and take action immediately.
More details

Helicobacter Pylori IgG Assay
Premier H. pylori

Premier H. pylori is a streamlined, highly sensitive enzyme immunoassay for the in vitro qualitative detection of IgG antibodies to Helicobacter pylori in human serum and plasma. The test results are intended to aid in the diagnosis of H. pylori infection.
More details

Urea Breath Test System for H. Pylori
BreathID Hp Lab

The BreathID Hp Lab is a state-of-the-art urea breath test system for H. pylori detection that intuitively combines market-leading diagnostic accuracy with efficient automation and fast batch-test analysis for maximizing large lab testing throughput. It offers a user-friendly interface and a cost-effective clinical diagnostic solution that can be used in any clinical setting, including office-based practices, hospitals, laboratories and the ICU.
More details

Fluorescence Immunoassay Analyzer
Curian

Curian is an efficient fluorescence immunoassay platform focused in gastrointestinal testing that is packaged in a small footprint to improve hospital operational efficiencies. Curian provides healthcare systems a rapid fluorescence immunoassay diagnostic solution with a standardized, simplified workflow that eliminates subjectivity. Laboratories can eliminate workflow burdens and achieve optimal efficiency while delivering top-of-the-line patient care.
More details

LAMP Molecular Diagnostic System
Alethia

The Alethia is an affordable LAMP (loop-mediated isothermal amplification) based molecular platform with a simple to use instrument that generates between 1 - 10 qualitative results in less than one hour. The molecular platform addresses your lab’s broad-spectrum needs, simply and accurately, with results that enable evidence-based health decisions.
More details

SARS-CoV-2 Recombinant Antigens
SARS-CoV-2 Recombinant Antigens

Meridian’s recombinant antigens are expressed in human mammalian cells and insect cells using proprietary expression and purification technologies. Expression in either human or insect cells provides for post-translational modifications such as glycosylation and phosphorylation which can offer significant performance advantages over E. coli expressed formats.
More details

SARS-CoV-2 High Sensitivity Antibodies
SARS-CoV-2 High Sensitivity Antibodies

Meridian’s monoclonal antibodies are highly sensitive for the detection of SARS-CoV-2 and they do not cross-react with seasonal coronavirus strains. They are ideal for developing reliable and sensitive rapid lateral flow antigen assays for the detection of active COVID-19 infections.
More details

Molecular Reagents
Molecular Reagents

Meridian’s portfolio of RT-qPCR master mixes have been designed to simplify the development of SARS-CoV-2 molecular assays and enable new features such as extraction-free amplification. Each master mix contains a hot-start polymerase, dNTPs, buffer and other components optimized for each particular application (e.g. lyophilization). Only primers and probes are required to complete the assay formula. Meridian has developed an Inhibitor-Tolerant RT-qPCR Mix capable of delivering sensitive multiplex detection, even in the presence of difficult inhibitors found in sputum, saliva and stool specimens. This new mix offers a novel alternative to nucleic acids extraction, saving both time and labor which are vitally important in viral screening assays that require rapid detection for infection control.
More details

Molecular Diagnostic Instrument
Revogene

Revogene is a flexible molecular platform capable of single analyte and multiplex testing that is packaged in a small footprint, and can help standardize testing throughout the health system. The fully automated molecular platform offers minimal hands-on time with walk-away efficiencies.
More details

COVID-19 IgG/IgM Test
QuikPac II 2019 COVID-19

The QuikPac II 2019 COVID-19 IgG and IgM Test is a qualitative test for the detection of IgG and IgM antibodies to COVID-19 in human serum, plasma or whole blood. The test provides a differential detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-IgG antibodies and can be used for the presumptive distinction between a primary and secondary Coronavirus infection.
More details

SARS-CoV-2 Antigen Test
GenBody COVID-19 Ag

GenBody COVID-19 Ag is an immunochromatographic assay kit for the qualitative detection of SARS-CoV-2 antigen in a nasopharyngeal swab from humans. The lateral flow immunoassay offers detection of active infection caused by SARS-CoV-2 in 15 minutes and allows for near patient testing without the need of instrumentation or special equipment.
More details

Immunoassay Test
TRU FLU

The TRU FLU is a rapid, 15-minute assay for the detection and differentiation of influenza A and influenza B. The closed system limits exposure to influenza during test incubation and disposal, and offers superior performance on flu A, which has much higher prevalence and virulence than flu B.
More details

Immunoassay Test
ImmunoCard STAT! Strep A

The ImmunoCard STAT! Strep A is a rapid immunoassay for the detection of Group A Streptococcal antigen. It has a shelf life of 10 months and can be stored in room temperature.
More details

Immunoassay Test
ImmunoCard Mycoplasma

The ImmunoCard Mycoplasma is the only rapid EIA for the detection of IgM to Mycoplasma pneumoniae in human serum. It offers a simple four-step procedure for the detection of active Mycoplasma pneumoniae infection in just nine minutes.
More details

Incubator/Reader
illumipro-10

The illumipro-10 is an automated isothermal amplification and detection system that combines Loop-Mediated Isothermal Amplification (LAMP) technology with a very simple assay process. It provides continuous access while running up to 10 samples at a time in two independent five-sample chambers and displays the results directly on a LED readout screen.
More details

HpSA Immuonoassay
ImmunoCard STAT HpSA

The ImmunoCard STAT HpSA is a rapid one-step immunoassay for the detection of H. pylori antigens in human stool that can be used to diagnose, monitor and confirm eradication. The monoclonal antibody-based test can provide accurate results in five minutes and has a shelf life of 24 months from the date of manufacture.
More details

Point-Of-Care Testing

POC Blood Lead Poisoning Test
LeadCare II

LeadCare II is the only CLIA waived point-of-care test for blood lead poisoning and can screen in a single visit with a simple finger-stick in just three minutes. The system includes the LeadCare II Blood Lead Analyzer and the LeadCare II Test Kit and is designed for the quantitative measurement of lead in fresh whole blood.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions